RCMI Coordinating Center (RCMI CC) Header Logo

Connection

John Piletz to Receptors, Drug

This is a "connection" page, showing publications John Piletz has written about Receptors, Drug.
Connection Strength

5.846
  1. Halaris A, Piletz JE. Relevance of imidazoline receptors and agmatine to psychiatry: a decade of progress. Ann N Y Acad Sci. 2003 Dec; 1009:1-20.
    View in: PubMed
    Score: 0.235
  2. Ma JK, Zhu HE, Piletz JE. Effect of postmortem delay on imidazoline receptor-binding proteins in human and mouse brain. Ann N Y Acad Sci. 2003 Dec; 1009:341-6.
    View in: PubMed
    Score: 0.235
  3. Zhu H, Piletz JE. Association between I(2) binding sites and monoamine oxidase-B activity in platelets. Ann N Y Acad Sci. 2003 Dec; 1009:347-52.
    View in: PubMed
    Score: 0.235
  4. Piletz JE, Wang G, Zhu H. Cell signaling by imidazoline-1 receptor candidate, IRAS, and the nischarin homologue. Ann N Y Acad Sci. 2003 Dec; 1009:392-9.
    View in: PubMed
    Score: 0.235
  5. Musgrave IF, Dehle FC, Piletz J. Assembly of PRR-containing receptors on scaffolds: a model for imidazoline I(1)-receptor action. Ann N Y Acad Sci. 2003 Dec; 1009:413-8.
    View in: PubMed
    Score: 0.235
  6. Piletz JE, Deleersnijder W, Roth BL, Ernsberger P, Zhu H, Ziegler D. IRAS splice variants. Ann N Y Acad Sci. 2003 Dec; 1009:419-26.
    View in: PubMed
    Score: 0.235
  7. Chen MJ, Zhu HE, Piletz JE. Intracellular effect of imidazoline receptor on alpha(2A)-noradrenergic receptor. Ann N Y Acad Sci. 2003 Dec; 1009:427-38.
    View in: PubMed
    Score: 0.235
  8. Zhu H, Hayes J, Chen M, Baldwin J, Piletz JE. Relationship between platelet imidazoline receptor-binding peptides and candidate imidazoline-1 receptor, IRAS. Ann N Y Acad Sci. 2003 Dec; 1009:439-46.
    View in: PubMed
    Score: 0.235
  9. Piletz JE, Ordway GA, Rajkowska G, Zhu H, Klimek V, Swilley S, Duncan BJ, May W, Halaris AE. Differential expression of alpha2-adrenoceptor vs. imidazoline binding sites in postmortem orbitofrontal cortex and amygdala of depressed subjects. J Psychiatr Res. 2003 Sep-Oct; 37(5):399-409.
    View in: PubMed
    Score: 0.231
  10. Zhu H, Paul IA, Stec DE, Peeler DF, Piletz JE. Non-adrenergic exploratory behavior induced by moxonidine at mildly hypotensive doses. Brain Res. 2003 Feb 21; 964(1):9-20.
    View in: PubMed
    Score: 0.223
  11. Piletz JE, Ordway GA, Zhu H, Duncan BJ, Halaris A. Autoradiographic comparison of [3H]-clonidine binding to non-adrenergic sites and alpha(2)-adrenergic receptors in human brain. Neuropsychopharmacology. 2000 Dec; 23(6):697-708.
    View in: PubMed
    Score: 0.191
  12. Piletz JE, Zhu H, Ordway G, Stockmeier C, Dilly G, Reis D, Halaris A. Imidazoline receptor proteins are decreased in the hippocampus of individuals with major depression. Biol Psychiatry. 2000 Nov 01; 48(9):910-9.
    View in: PubMed
    Score: 0.190
  13. Piletz JE, Halbreich U. Imidazoline and alpha(2a)-adrenoceptor binding sites in postmenopausal women before and after estrogen replacement therapy. Biol Psychiatry. 2000 Nov 01; 48(9):932-9.
    View in: PubMed
    Score: 0.190
  14. Piletz JE, Ivanov TR, Sharp JD, Ernsberger P, Chang CH, Pickard RT, Gold G, Roth B, Zhu H, Jones JC, Baldwin J, Reis DJ. Imidazoline receptor antisera-selected (IRAS) cDNA: cloning and characterization. DNA Cell Biol. 2000 Jun; 19(6):319-29.
    View in: PubMed
    Score: 0.185
  15. Zhu H, Halaris A, Madakasira S, Pazzaglia P, Goldman N, DeVane CL, Andrew M, Reis D, Piletz JE. Effect of bupropion on immunodensity of putative imidazoline receptors on platelets of depressed patients. J Psychiatr Res. 1999 Jul-Aug; 33(4):323-33.
    View in: PubMed
    Score: 0.173
  16. Piletz JE, Jones JC, Zhu H, Bishara O, Ernsberger P. Imidazoline receptor antisera-selected cDNA clone and mRNA distribution. Ann N Y Acad Sci. 1999 Jun 21; 881:1-7.
    View in: PubMed
    Score: 0.173
  17. Head GA, Chan CK, Zhu H, Piletz JE. Dissociation of the effects of intramedullary monoamine neurotoxins on the hypotensive action of moxonidine and on immunodetected imidazoline and alpha 2-receptor proteins. Ann N Y Acad Sci. 1999 Jun 21; 881:300.
    View in: PubMed
    Score: 0.173
  18. Halaris A, Zhu H, Feng Y, Piletz JE. Plasma agmatine and platelet imidazoline receptors in depression. Ann N Y Acad Sci. 1999 Jun 21; 881:445-51.
    View in: PubMed
    Score: 0.173
  19. Ivanov TR, Jones JC, Dontenwill M, Bousquet P, Piletz JE. Characterization of a partial cDNA clone detected by imidazoline receptor-selective antisera. J Auton Nerv Syst. 1998 Oct 15; 72(2-3):98-110.
    View in: PubMed
    Score: 0.165
  20. Ivanov TR, Zhu H, Regunathan S, Reis DJ, Dontenwill M, Vonthron C, Bousquet P, Piletz JE. Co-detection by two imidazoline receptor protein antisera of a novel 85 kilodalton protein. Biochem Pharmacol. 1998 Mar 01; 55(5):649-55.
    View in: PubMed
    Score: 0.158
  21. Piletz JE, Andrew M, Zhu H, Feng YZ, Rains J, Halaris A. Alpha 2-adrenoceptors and I1-imidazoline binding sites: relationship with catecholamines in women of reproductive age. J Psychiatr Res. 1998 Mar-Apr; 32(2):55-64.
    View in: PubMed
    Score: 0.158
  22. Ivanov TR, Feng Y, Wang H, Regunathan S, Reis DJ, Chikkala DN, Gupta P, Jones JC, Piletz JE. Imidazoline receptor proteins are regulated in platelet-precursor MEG-01 cells by agonists and antagonists. J Psychiatr Res. 1998 Mar-Apr; 32(2):65-79.
    View in: PubMed
    Score: 0.158
  23. Reis DJ, Piletz JE. The imidazoline receptor in control of blood pressure by clonidine and allied drugs. Am J Physiol. 1997 11; 273(5):R1569-71.
    View in: PubMed
    Score: 0.154
  24. Zhu H, Paul IA, McNamara M, Redmond A, Nowak G, Piletz JE. Chronic imipramine treatment upregulates IR2-imidazoline receptive sites in rat brain. Neurochem Int. 1997 Jan; 30(1):101-7.
    View in: PubMed
    Score: 0.146
  25. Zhu H, Halaris A, Piletz JE. Chronic imipramine treatment downregulates IR1-imidazoline receptors in rat brainstem. Life Sci. 1997; 61(19):1973-83.
    View in: PubMed
    Score: 0.146
  26. Piletz JE, Zhu H, Chikkala DN. Comparison of ligand binding affinities at human I1-imidazoline binding sites and the high affinity state of alpha-2 adrenoceptor subtypes. J Pharmacol Exp Ther. 1996 Nov; 279(2):694-702.
    View in: PubMed
    Score: 0.144
  27. Piletz JE, Halaris A, Nelson J, Qu Y, Bari M. Platelet I1-imidazoline binding sites are elevated in depression but not generalized anxiety disorder. J Psychiatr Res. 1996 May-Jun; 30(3):147-68.
    View in: PubMed
    Score: 0.139
  28. Piletz JE, Halaris AE, Chikkala D, Qu Y. Platelet I1-imidazoline binding sites are decreased by two dissimilar antidepressant agents in depressed patients. J Psychiatr Res. 1996 May-Jun; 30(3):169-84.
    View in: PubMed
    Score: 0.139
  29. Piletz JE, Halaris A. Involvement of I1-imidazoline receptors in mood disorders. Ann N Y Acad Sci. 1995 Jul 12; 763:510-9.
    View in: PubMed
    Score: 0.132
  30. Piletz JE, Chikkala DN, Ernsberger P. Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors. J Pharmacol Exp Ther. 1995 Feb; 272(2):581-7.
    View in: PubMed
    Score: 0.128
  31. Piletz JE, Sletten K. Nonadrenergic imidazoline binding sites on human platelets. J Pharmacol Exp Ther. 1993 Dec; 267(3):1493-502.
    View in: PubMed
    Score: 0.118
  32. Chan CK, Burke SL, Zhu H, Piletz JE, Head GA. Imidazoline receptors associated with noradrenergic terminals in the rostral ventrolateral medulla mediate the hypotensive responses of moxonidine but not clonidine. Neuroscience. 2005; 132(4):991-1007.
    View in: PubMed
    Score: 0.063
  33. Zhu H, Halaris A, Piletz JE. Atypical [(3)H]clonidine binding sites in human caudate and platelets on cryostat-cut sections. Ann N Y Acad Sci. 2003 Dec; 1009:296-301.
    View in: PubMed
    Score: 0.059
  34. Ernsberger P, Piletz JE, Graff LM, Graves ME. Optimization of radioligand binding assays for I1-imidazoline sites. Ann N Y Acad Sci. 1995 Jul 12; 763:163-8.
    View in: PubMed
    Score: 0.033
  35. Dontenwill M, Piletz JE, Chen M, Baldwin J, Pascal G, Ronde P, Dupuy L, Greney H, Takeda K, Bousquetd P. IRAS is an anti-apoptotic protein. Ann N Y Acad Sci. 2003 Dec; 1009:400-12.
    View in: PubMed
    Score: 0.015
  36. Halbreich U, Piletz JE, Carson S, Halaris A, Rojansky N. Increased imidazoline and alpha 2 adrenergic binding in platelets of women with dysphoric premenstrual syndromes. Biol Psychiatry. 1993 Nov 15; 34(10):676-86.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support